Particle accelerators have been instrumental in advancements across research, industry, medicine, and more. However, their widespread use is hindered by significant cost and size constraints, particularly affecting hospitals, universities, and small to medium-sized enterprises.
EuPRAXIA is the first European project that develops a dedicated particle accelerator research infrastructure based on novel plasma acceleration concepts driven by innovative laser and linac technologies.
The project aims at the construction of an innovative electron accelerator using laser- and electron-beam-driven plasma wakefield acceleration that offers a significant reduction in size and possible savings in cost over current state-of-the-art radiofrequency-based accelerators.
The EuPRAXIA seminar series will cover the role of simulations and diagnostics in developing plasma accelerators, the principles and applications of free electron lasers, innovative linac technologies, the advantages of beam-driven plasma wakefield acceleration and key applications of plasma accelerators beyond conventional technologies.
